DekaBank Deutsche Girozentrale - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 95 filers reported holding THERAVANCE INC in Q4 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$640,000
+51.7%
59,800
+1.7%
0.01%
+40.0%
Q3 2015$422,000
-58.9%
58,800
+3.5%
0.01%
-58.3%
Q2 2015$1,026,000
+19.3%
56,800
+3.8%
0.01%
+9.1%
Q1 2015$860,000
-3.6%
54,700
-11.3%
0.01%0.0%
Q4 2014$892,000
-22.4%
61,700
-8.3%
0.01%
-31.2%
Q3 2014$1,150,000
-40.2%
67,300
+4.2%
0.02%
-44.8%
Q2 2014$1,924,000
-8.6%
64,600
-5.0%
0.03%
-12.1%
Q1 2014$2,104,000
-1.6%
68,000
+11.3%
0.03%
-5.7%
Q4 2013$2,139,000
-5.9%
61,100
+9.9%
0.04%
-12.5%
Q3 2013$2,273,00055,6000.04%
Other shareholders
THERAVANCE INC shareholders Q4 2015
NameSharesValueWeighting ↓
Baupost Group 20,144,301$718,144,00020.35%
Litespeed Management, L.L.C. 1,636,994$58,359,0008.44%
Realm Partners LLC 240,794$8,585,0007.27%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,828,059$100,820,0004.97%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,456,503$265,824,0003.15%
SECTORAL ASSET MANAGEMENT INC 1,973,188$70,344,0003.03%
Foundation Asset Management, LP 221,796$7,907,0002.06%
Rhenman & Partners Asset Management AB 132,000$4,706,0001.84%
BB BIOTECH AG 888,244$31,666,0001.69%
HealthCor Management, L.P. 725,000$25,846,0001.57%
View complete list of THERAVANCE INC shareholders